|

Impact of P53 and SIRT1 in Type 2 Diabetes

RECRUITINGPhase 3Sponsored by Sherief Abd-Elsalam
Actively Recruiting
PhasePhase 3
SponsorSherief Abd-Elsalam
Started2019-04-01
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03925714

Summary

Investigating the impact of p53 and SIRT1 in the development of type 2 DM

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Prediabetic subjects.

Exclusion Criteria:

* Confirmed diabetes.
* Hepatic or renal impairment.

Conditions2

DMDiabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.